Kestra Private Wealth Services LLC raised its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL) in the most recent reporting period. Citigroup lifted their target price on shares of the company from $190.

Kestra Private Wealth Services LLC raised its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL) in the most recent reporting period. Citigroup lifted their target price on shares of the company from $190.00 to $215.00. Barclays PLC Grows Stake in Kanzhun Limited. Charles River Laboratories International may potentially be a promising investment. Citigroup upped their price on Charles River Labs International from $190,000 to $210,000.